Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kid ASA - Invitation to presentation of Third quarter 2022 results

Lier, 4 November 2022: Kid ASA will release its third quarter 2022 results on Tuesday 8 November 2022. The quarterly report and presentation material will be available on http://investor.kid.no and http://newsweb.no from 07:30 CET.The results will be presented at 09:00 CET by CEO Anders Fjeld and CFO Eystein Lund at the offices of ABG Sundal Collier, Ruseløkkveien 26, 8[th] floor, Oslo. To participate during the presentation or for meeting bookings with Kid management, please contact Kjersti Syversen (+4793409339) by e-mail kjersti.syversen@abgsc.no        The presentation will also

1.3 billion yuan in intended deals recorded at CIIE for Elkem

Under the theme of “Silicon for a Zero-Carbon Future”, Elkem, a technology leader with over seven decades of expertise in the silicone industry, showcases four segments “Life Science”, “Consumer Goods”, “Smart City” and “Inno-Life” at the Consumer Goods Exhibition Area of the 5th China International Import Expo (Booth B1-01, Hall 5.1) from November 5 to 10, 2022. The company will promote here its innovative technologies and low-carbon sustainable solutions for industries including healthcare, construction, homecare, automotive, energy and 3D printing, and China Sinochem e-commerce platform

Nomination Committee for the 2023 Annual General Meeting

MilDef Group AB's Nomination Committee consists of the following members:· Ulf Hedlundh, appointed by Svolder AB (publ), Chairman of the Nomination Committee · Peter Lundkvist, appointed by Tredje AP-fonden · Marianne Trolle, who represents her own ownership in MilDef · Jan Andersson, Chairman of the Board in MilDef The nomination committee has the same composition as for the 2022 annual general meeting. Information about the Nomination Committee's work is available on MilDef's website Nomination Committee – MilDef Investors 

Kid ASA - Lower than expected gross margin in Q3 2022

Lier, 4 November 2022.Kid will in Q3 2022 report lower than expected gross margin due to high freight cost. Overseas freight cost expressed as percentage of cost of goods sold was 21.7% in Q3 2022, up from 10.9% in Q3 2021. Our price model has not sufficiently taken into consideration the volatility in fright cost and consequently not been reflected in increased sales prices. The reported gross margin was 55.5% in Q3 2022, down from 61.4% in Q3 last year. The higher freight cost is also expected to negatively impact the gross margin for Q4 2022 and into 2023. With freight spot

Listing of Derivatives at NGM #22-378

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Invitation to presentation of 3rd quarter 2022 results

In connection with the release of the 3rd quarter 2022 results, Bonheur ASA will publish its 3rd quarter 2022 report on Tuesday 8 November at 09:00 CET, by way of a webcast. To watch presentation in a webcast, use this link: https://edge.media-server.com/mmc/p/qdy93oa9 To listen to the presentation and ask questions via telephone please use the below call in details: Conference Call Dial-In: Conference ID: 3996244#Denmark, National +45 32 74 07 10Denmark, Toll-Free +45 80 83 06 62Norway, National +47 57 98 94 30Sweden, Stockholm +46

DanCann Pharma A/S publishes a supplement to the prospectus for the rights issue

COPENHAGEN, Denmark, November 4, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announces that the Company has published a supplement to the prospectus for the rights issue which was published on October 21, 2022 (the “Supplement” and the “Prospectus”). The reasons for the Supplement are the publications of the Q3-2022 report and the signing of a supply agreement with Storkpharm SP. z o.o. for the Polish Market.The Supplement, which today has been approved and registered by the Danish Financial Supervisory

BioStock: Chordate’s migraine study paves way for planned exit

The final study results from Chordate Medical’s migraine study PM007 demonstrate a statistically significant effect, confirming the German subgroup results presented at the end of September. The study included 140 patients with chronic migraine and the aim was to evaluate the efficacy and safety of the K.O.S. treatment. The patients who received active treatment got a statistically significantly reduced number of monthly headache days compared to those who received sham treatment. No adverse events were reported. BioStock contacted CEO Anders Weilandt for a comment.Read the interview with

Photocure Partner Asieris announces 1[st] Patient enrolled in Hexvix Phase III trial in China

Press Release – Oslo, Norway, November 4, 2022: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today on the treatment of the first patient in the Hexvix[®] phase III bridging trial.The objective of the multicenter Phase III trial is to achieve regulatory approval of Hexvix in Mainland China for use in patients with bladder cancer, by investigating the detection rate and safety of Hexvix and blue light cystoscopy (BLC[®]) versus white light cystoscopy in patients with non-muscle invasive bladder cancer (

Minutes of the Extraordinary general meeting

Cessatech A/S, CVR no. 41 29 30 55 (“Cessatech” or the “Company”) held an extraordinary general meeting on Friday 4 November 2022, at 8:00 (CET) as a physical event with the possibility to attend via webcast.The agenda for the general meeting was as follows: 1. Election of the chairman of the meeting 2. Proposals from the board of directors 1. Proposal to authorize the board of directors to issue warrants and to resolve on the associated capital increase 2. Proposal to authorize the board of directors to increase the share capital 3. Any other business ---oo0oo--- Re.

Flowscape wins business in Norway

Another Norwegian municipality chooses to install Flowscape's solution for the new hybrid way of working  The order value in the first year is SEK 230,000 and thereafter SEK 180,000 annually recurring"We are very happy to receive the trust of another municipality in Norway. The order comes after a pilot for few months. The municipality's goal is to create a modern workplace adapted to the new hybrid way of working . They want to make it easier for the staff to plan which days of the week they will be in the office and give

Invitation to presentation of Synsam Group’s Q3 report 2022

Presentation in Swedish, with possibility to ask questions · Date and time: 16 November 2022, at 09.00 CET. · Place: Webcast with teleconference. · Speakers: President and CEO Håkan Lundstedt and CFO Per Hedblom. · Registration for participation in webcast with teleconference:https://financialhearings.com/event/43978 Presentation in English, with possibility to ask questions · Date and time: 16 November 2022, at 10.30 CET. · Place: Webcast with teleconference. · Registration for participation in webcast with teleconference:https://financialhearings.com/

Penneo extends the agreement with Bankdata

Company Announcement No. 30-2022Copenhagen, 4 November 2022Penneo announces that it’s expanding the agreement with Bankdata, extending the usage of Penneo Sign to the private customers of Bankdata’s member institutions.  In company announcement No. 32-2021, Penneo announced an agreement to roll out Penneo’s Sign software in the eight financial institutions of Bankdata and in Denmark. Bankdata now expands the collaboration, as Bankdata’s member institutions extend the usage to include signing for their private customers. The expanded cooperation is of strategic importance and

Cell Impact reports third quarter results: Product and production adjustments result in temporarily lower sales

Cell Impact AB (Nasdaq First North GM: CI) reports the following financial summary for the third quarter.· Total revenues amounted to SEK 14.7 million (27.5), down -46% compared with the corresponding Quarter of 2021. · Operating loss was SEK -28.6 million (-14.4). · The Group's loss after financial items was SEK -28.9 million (-14.7). · Earnings per share attributable to the shareholders of the Parent Company totaled SEK -0.38 (-0.25). · Equity was SEK 353.3 million (149.3) or SEK 4.66 per share (2.54) on the balance sheet date. · Debt/equity ratio was 81% (73) on the

RKW at the Eurotier 2022 in Hannover from November 15-18, 2022, Hall 27, Booth E50

Michelstadt, October 26, 2022 - From November 15-18, the RKW Group will present its Polydress TWISTA silage film as a new product family for the first time, expanding its wide range of solutions for the agar sector with this premium solution. Polydress TWISTA is now available in three different variants.Polydress TWISTA - saves labor and conserves resources Thanks to patented folding technology, Polydress TWISTA combines silage and underlay film on one roll. This means that both films can be laid out in just one step, reducing the amount of work required to cover the silo by 50%. Due to

Company announcement no. 117, 2022 - Auctions of covered mortgage bonds in Nordea Kredit Realkreditaktieselskab

The refinancing of Nordea Kredit ARMs with annual refinancing on 1 January 2023 will be conducted via auctions of covered mortgage bonds (SDRO). The covered mortgage bonds are rated AAA by Standard & Poor´s.   The auctions will be performed by Nordea Bank Abp and will be held at either the NASDAQ Copenhagen auction market or Bloomberg AUPD on Friday, 18 November 2022.   The auctions will open daily at 9.00 a.m. and close either by 10.00 a.m. or 10.30 a.m.. Investors will be notified of accepted bids as soon as possible after the closing of the auctions but no later than by 10.10

Last day of trading in BTU

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES. Clean Industry Solutions Holding Europe AB's (publ) ("Clean Industry Solutions" or the "Company") rights issue of units, which was resolved by the Company's Board of Directors on 20 September 2022, has now been registered with

BioStock: SynAct Pharma's CSO comments approved IND and Q3

SynAct Pharma has received IND approval from the FDA, meaning that they can initiate the phase IIa/b RESOLVE study of AP1189 in DMARD-IR patients. They have also just published their report for the third quarter, a busy period with significant progress in the development programmes with AP1189. CSO Thomas Jonassen visited BioStock's studio to talk about the IND approval, patient recruitment in the EXPAND study, financing, and partnering discussions.Watch the interview with SynAct Pharma's CSO Thomas Jonassen at biostock.se: https://www.biostock.se/en/2022/11/synact-pharmas-cso-comments-

Nomination Committee for the AGM 2023.

In accordance with the decision at Formpipe Software's Annual General Meeting on April 27, 2022, the Chairman, Annikki Schaeferdiek, has called together the Nomination Committee. After consultation with the company's, as of September 30, 2022, largest shareholder in terms of votes, the Nomination Committee consists of the following members: · Marika Svärdström become Chairman of the Nomination Committee representing Martin Bjäringer 4.670.000 shares, Alcur Select 4.323.627 and Alcur 328.159 shares, corresponding to 17.19% of the votes · Emil Ivarsson representing Grenspecialisten AB,

Trading Statement for 1 January – 30 September 2022

Company Announcement No 37/2022 HusCompagniet generated a revenue of more than DKK 1 billion, bringing the year-to-date revenue to DKK 3.4 billion equivalent to a growth of 7.6%. EBITDA before special items (bsi) margin in Q3 was 9.7% which is the highest during current financial year and driven by a recovery of gross margin and lower SG&A due to several adjustments of the organisation. Market conditions were challenging with sales of 138 in Q3, 75% below Q3 2021.“I am pleased with the financial results in Q3, especially the improvements in our margins compared to prior quarters which

BioStock: DanCann Pharma rides the cannabis legalisation wave

We are seeing a shift in the political will to decriminalise cannabis, not least in the US and Germany, where significant steps in legislature are being considered. This will also have important effects on the field of medical cannabis, which has already seen a tectonic shift towards a more general acceptance in recent years. Danish biopharma company DanCann Pharma, with one of the world’s most modern facilities for manufacturing medical cannabis, is one of the top European players in this field. To inch closer to profitability, the company is now carrying out a rights issue of 28.5 million

Peptonic Medical's ongoing applications for the intimate wash and for the treatment of fungal infection has received positive statements from the international review

Peptonic Medical has previously announced that it applied for patents for the intimate wash and for the treatment of fungal infections, which have been accompanied by so-called PCT applications (Patent Cooperation Treaty). Both applications have now been reviewed by the international review authority, the outcome is that they recommend that patents be granted, as the patent applications meet the requirements for novelty, inventive step and industrial applicability. Now it remains to submit applications at the national level and get the applications granted there.• The first applied for

Correction: Key information relating to payment of cash dividend paid by Aker ASA

Reference is made to the notification on 4 November at 07:01 CET. The timeline is deferred by one day due to notification requirements from the Oslo Stock Exchange.Dividend amount: NOK 14.50 per shareDeclared currency: NOKLast day including right: 7 November 2022*Ex-date: 8 November 2022*Record date: 9 November 2022*Payment date: On or about 16 November 2022Approval date: 3 November 2022 -END- For further information, please contact: Fredrik Berge, Head of Investor Relations Aker ASAmobile: +47 450 32 090fredrik.berge@akerasa.com Atle Kigen, Head of Media

Drilling of the Calypso exploration well (PL938) has started

(Trondheim, 4 November 2022) OKEA ASA (OSE: OKEA) announces that drilling operations on the Neptune Energy-operated Calypso exploration well (6407/8-8 S), in the Norwegian Sea, have commenced from the Deepsea Yantai rig. The well will be drilled 14 km north-west of the OKEA-operated Draugen field and a discovery could be tied-back to the Draugen platform or the Njord platform. The main prospect lies in the Jurassic Garn, Ile and Tilje formations at a depth of approximately 3,000 m. OKEA holds a 30% working interest (“WI”) in the licence.   The drilling programme comprises a main well

There are no items matching the current filter
There are no more items matching the current filter
Back to top